Deciphera Pharmaceuticals, Inc. (DCPH)
NASDAQ: DCPH · IEX Real-Time Price · USD
15.73
+0.55 (3.62%)
At close: Mar 28, 2024, 4:00 PM
16.04
+0.31 (1.97%)
After-hours: Mar 28, 2024, 6:44 PM EDT
Deciphera Pharmaceuticals Market Cap
Deciphera Pharmaceuticals has a market cap or net worth of $1.27 billion as of March 28, 2024. Its market cap has increased by 8.60% in one year.
Market Cap
1.27B
Enterprise Value
990.65M
1-Year Change
8.60%
Ranking
Category
Stock Price
$15.73
Market Cap Chart
Since September 28, 2017, Deciphera Pharmaceuticals's market cap has increased from $541.50M to $1.27B, an increase of 134.72%. That is a compound annual growth rate of 14.03%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 27, 2024 | 1.23B | 2.42% |
Mar 26, 2024 | 1.20B | -3.13% |
Mar 25, 2024 | 1.24B | 0.46% |
Mar 22, 2024 | 1.23B | -1.74% |
Mar 21, 2024 | 1.25B | -1.59% |
Mar 20, 2024 | 1.27B | 5.21% |
Mar 19, 2024 | 1.21B | 0.81% |
Mar 18, 2024 | 1.20B | -4.75% |
Mar 15, 2024 | 1.26B | -2.01% |
Mar 14, 2024 | 1.29B | -0.44% |
Mar 13, 2024 | 1.29B | -0.68% |
Mar 12, 2024 | 1.30B | -2.72% |
Mar 11, 2024 | 1.34B | -2.37% |
Mar 8, 2024 | 1.37B | 0.07% |
Mar 7, 2024 | 1.37B | - |
Mar 6, 2024 | 1.37B | 0.77% |
Mar 5, 2024 | 1.36B | 1.14% |
Mar 4, 2024 | 1.34B | -4.32% |
Mar 1, 2024 | 1.40B | 4.01% |
Feb 29, 2024 | 1.35B | -0.71% |
Feb 28, 2024 | 1.36B | -0.59% |
Feb 27, 2024 | 1.37B | 2.85% |
Feb 26, 2024 | 1.33B | 2.37% |
Feb 23, 2024 | 1.30B | 1.96% |
Feb 22, 2024 | 1.27B | 2.27% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Collegium Pharmaceutical | 1.30B |
Belite Bio | 1.29B |
Tarsus Pharmaceuticals | 1.28B |
Silence Therapeutics | 1.27B |
Pharvaris | 1.26B |
Brookdale Senior Living | 1.22B |
Ligand Pharmaceuticals | 1.22B |
Liquidia | 1.21B |